Anaplasia is a term pathologists use to describe cancer cells that have lost the appearance and organization of the normal cells they came from. In healthy tissue, cells are differentiated — meaning they have developed specialized shapes and functions suited to the organ they belong to. Anaplastic cells have shed this specialization entirely. They look abnormal, disorganized, and bear little resemblance to normal tissue. Finding anaplasia in a tumor is a sign of high-grade, aggressive behavior and indicates that the cancer is likely to grow and spread more quickly than tumors without this feature.
When a pathologist examines anaplastic tissue, several abnormal features stand out:

Anaplasia is closely related to the concept of grade, the system pathologists use to describe how abnormal tumor cells look compared to normal tissue. Grade is based on the degree of differentiation:
Anaplasia is therefore a defining feature of high-grade tumors. The more anaplastic a tumor is, the higher its grade tends to be, and the more aggressively it is likely to behave.
The word “anaplastic” appears in the names of several specific cancer types, where it signals a particularly aggressive form of that cancer:
Anaplasia can also be found as a feature of many other high-grade cancers, even when the word “anaplastic” does not appear in the tumor’s name.
Finding anaplasia in a tumor is a significant pathological finding. It indicates that the cancer cells have lost their normal identity and organization, which is generally associated with more aggressive behavior — faster growth, a higher likelihood of spread, and a greater risk of recurrence after treatment. Anaplasia is almost exclusively seen in malignant (cancerous) tumors; finding it in a benign tumor is exceedingly rare.
However, anaplasia is only one part of the overall picture. Prognosis and treatment decisions are based on the full pathology report — including the tumor type, stage, and any biomarker results — not on any single feature. Aggressive tumors may require more intensive treatment, but many high-grade cancers respond well to chemotherapy, radiation, immunotherapy, or targeted therapies. Your oncologist will interpret the finding of anaplasia in the context of your complete diagnosis.